Back
Cartesian Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
26
RNAC
Cartesian Therapeutics
Last Price:
16.61
Seasonality Move:
13.13%
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
249.11
Seasonality Move:
10.85%
Sell
26
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $16.94. The Score for RNAC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $16.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $248.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.75 | Sell |
| Relative Strength Index (14 RSI): | 39.42 | Sell |
| Chaikin Money Flow: | -99129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.09 - 22.05) | Sell |
| Bollinger Bands (100): | (14.31 - 20.45) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.64 | Sell |
| Relative Strength Index (14 RSI): | 39.68 | Sell |
| Chaikin Money Flow: | 997085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (254.01 - 292.55) | Sell |
| Bollinger Bands (100): | (248.69 - 281.73) | Sell |
RNAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.66 | Sell |
| 20-day SMA: | 19.51 | Sell |
| 50-day SMA: | 19.31 | Sell |
| 200-day SMA: | 20 | Sell |
| 8-day EMA: | 17.92 | Sell |
| 20-day EMA: | 18.95 | Sell |
| 50-day EMA: | 19.03 | Sell |
| 200-day EMA: | 21.01 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 252.75 | Sell |
| 20-day SMA: | 267.61 | Sell |
| 50-day SMA: | 273.13 | Sell |
| 200-day SMA: | 210.87 | Buy |
| 8-day EMA: | 250.09 | Sell |
| 20-day EMA: | 262.36 | Sell |
| 50-day EMA: | 266.92 | Sell |
| 200-day EMA: | 230.73 | Buy |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Cartesian Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||